Chicago-Members of the Society of University Urologists have agreed tocreate a new group consisting of U.S.-based urology program directors. Thenew, yet-unnamed organization will have both fund-raising and task-orientedresponsibilities, including assisting programs with new competency requirements,said Robert Flanigan, MD, professor and chairman of the department of urologyat Loyola University, Maywood, IL, who will serve as president of the group.Other officers will include Marc Cohen, MD, of the Medical College ofGeorgia in Augusta; and Michael Koch, MD, of Indiana University, Indianapolis.
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
In a head-to-head RCT, Rezūm produced a 4.6-point greater IPSS improvement than combination pharmacotherapy at 1 year, according to Jean-Nicolas Cornu, MD, PhD, FEBU.
Enfortumab vedotin-ejfv (Padcev) plus pembrolizumab (Keytruda) showed the strongest EFS, OS, and PCR associations among neoadjuvant MIBC strategies in a network meta-analysis, although perioperative design limits attribution.